depression

9511213674_31a3c06cc7_z

Introduction

Clinical, unipolar depression is more than just feeling low for a day or two.

Depression is characterised as episodes of sadness, loss of interest and pleasure, often including feelings of low self-worth. Depression can also include a range of physiological symptoms, such as fatigue, pain, diminished appetite, lack of interest in sex, disturbed sleep, and poor concentration.

The World Health Organisation estimates that, globally, as many as 350 million people are affected at any given time, with one person in 20 reporting an episode of depression in a 12 month period (in a global sample of 17 countries). They describe depression as the leading cause of disability worldwide.

What we know already

We know that, despite the considerable global burden of depression, not everybody receives treatment, with figures ranging from 50% to 10% in less developed countries.

Evidence suggests that combined psychological and pharmacological treatments seem to work well. Broadly, we know that psychotherapies work in many cases – but not every time. We know that neurochemical factors, such as serotonergic dysfunction, play an important role in depression, which goes a long way in explaining the efficacy of SSRI treatments.

We also know that depression has a nasty habit of recurrence, and some psychological interventions, such as Mindfulness-Based Cognitive Therapy (MBCT) is recommended particularly for people who have experienced multiple episodes of depression, but not are currently severely depressed.

We know that people living with chronic physical illness are more likely to experience depression, and this combination is linked with poorer clinical outcomes.

Importantly though, we know that people with depression can still enjoy themselves, and a common misconception in depression is that people feel totally awful all of the time.

Areas of uncertainty

There is much still to determine. For example, we know that depression is hereditable, however the extent of heredity versus environmental influences are unclear.

We are also unsure as to the precise mechanisms that determine those who respond best to treatments, be they psychopharmacological, or psychological, or both.

What’s in the pipeline?

Despite advances in our understanding of depression, and how it is treated, it remains a highly recurrent difficulty, with many people not achieving complete remission between episodes.

Preventative interventions, either physiological, or psychological, may improve people’s resilience to depression, particularly those identified as being highly prone.

References

Cuijpers, P. (2015). Psychotherapies for adult depression: recent developments. Current Opinion in Psychiatry, 28, 24-29. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK [PDF]

World Health Organisation (2015).Factsheet 369: Depression [Link]

Photo Credits

Sascha Kohlmann CC BY 2.0

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Nov 2015
Review due: Sep 2016

Our depression Blogs

Collaborative care may help older adults with subthreshold depression: CASPER trial

agent-18762_1280

Ben Hannigan summarises the new CASPER trial of collaborative care versus usual care for older adults with subthreshold depression.

[read the full story...]

Self-guided iCBT for depression: effective but still not sticky enough

apple-1853337_1280

Stefan Rennick-Egglestone highlights a brand new IPD meta-analysis of self-guided Internet-based cognitive behavioural therapy for the treatment of depression.

[read the full story...]

Psychotherapies for depression in children and adolescents: all of equal IMPACT?

sad-woman

Jasmin Wertz summarises the recently published IMPACT trial, which found that CBT, short-term psychoanalytical psychotherapy and brief psychosocial interventions (psychoeducation) were all equally effective in treating depression in children and young people.

[read the full story...]

Cochrane find insufficient evidence to support the implementation of depression prevention programmes

no-freedom-1886980_640

Ioana Cristea summarises the latest Cochrane review on CBT, third-wave CBT and IPT based interventions for preventing depression in children and adolescents

[read the full story...]

#MQScienceMeeting: transforming lives with better mental health research

MQ MHSM

André Tomlin looks back at the #MQScienceMeeting Mental Health Science Meeting that took place in London on 2-3 Feb 2017.

[read the full story...]

“Queer in the head”? Do LGB people in the UK have poorer mental health? #LGBTHM17

9443138198_b4fabbd4fa_k

At the start of LGBT History Month, Sarah Carr presents some recent research into sexual orientation and symptoms of common mental disorder or low wellbeing.

[read the full story...]

How do young adults with diabetes or mental health problems engage with online health information?

2352753067_5c69ba1417_o

Sarah Knowles explores a qualitative study of young adults’ perspectives on producing and consuming user-generated content about diabetes and mental health.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

Is there still a digital divide in mental health?

15115777092_31c07f2fd2_k

Lisa Marzano writes her debut elf blog on a recent cross-sectional survey of Internet use in people with psychosis and depression, which explores the extent of the digital divide in mental health.

[read the full story...]